Kick off 2025 and set the tone for the year as our 17th Annual
Pre-Filled Syringes and Injectable Drug Devices Conference will return to London in January to unite leaders from the industry, bringing you the latest advances in the combination product drug delivery space and the chance to collaborate across a 3 day programme.
As part of our leading
Injectable Drug Delivery Series, the 3-day event will comprise of a pre-conference focus day exploring the advances in
PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below addressing the industry's hottest topics:
- Device Innovations for Large Volume and Highly Viscous Drug Delivery
- Sustainability by Design and Material Selection
- Primary Packaging Development
- Digital Integration for Connected Devices
This event will not only bring you key insights needed to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in January 2025!
Featured Speakers
- Abha Raveau-Violette, Head of Project Management of Medical Devices and Combination Products, Sandoz
- Alphons Fakler, Director Human Factors Engineering/User Experience, Novartis
- Arabe Ahmed, Medicinal Technical Specialist, BSI
- Caroline Zakrzewski, Senior Engineer, AstraZeneca
- Cedric Gysel, Manager, Sustainable Innovation & Circular Economy Solutions at the Office of Sustainability, Johnson & Johnson
- Christian Proff, Senior Verification Engineer, Roche
- Claus Geiger, Global Device Leader, Sanofi
- Confirmed Representative, BioPhorum
- Cyril Thouseau, Head of Device and Packaging Vaccine LCM Portfolio, Sanofi - Global Device and Packaging Unit
- Daanish Ahmed Khan, Director, Novo Nordisk A/S
- Daniel McNaught, Head of External Manufacturing, Drug Product and Devices, UCB
- David Harrison, Business Lead, Drug Products and Devices, UCB
- Estefania Dos Anjos, Senior Product Specialist, TÜV SÜD
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
- Heinrich Martens, Vice President Regulatory Affairs, Fresenius Kabi
- Ian Thompson, Former Vice President Business Development,Delivery Systems, Ypsomed AG
- Jacqueline Schendel, Head of Laboratory, Boehringer Ingelheim
- James Whitehead, Senior Director, Devices & Digital Safety, AstraZeneca
- Joel Richard, Chief Development Officer, Enterome
- Joseph Burt, Head of Diagnostics, Innovative Devices, MHRA
- Juan Martin Carriquiry, EU MDR and IVDR Lead, Novartis
- Katharina Braun, Technical Expert Packaging & Labeling, Boehringer Ingelheim Pharma GmbH & Co. KG
- Khaudeja Bano, Former Vice President, Combination Product Quality, Amgen
- Laetitia Hourman, Associate Director in RA Device, Novo Nordisk
- Lou Azevedo Da Silva, Design Engineer, Sanofi
- Marc Egen, Head of Primary Packaging & Process Development, Boehringer Ingelheim Pharma Gmbh & Co. KG
- Mark Hassett, Vice President of Business Development, Credence MedSystems
- Michael Becker, Packaging Engineer, Boehringer Ingelheim Pharma GmbH & Co. KG
- Michael Kuehler, Senior MD Expert, Consistency of NBOp Assessments Working Group Leader, Bayer AG, EFFPIA
- Niels Otterstrom Jensen, Head of TakeBack Program, Novo Nordisk A/S
- Paul Picchione, Senior Product Assessment Expert, TÜV SÜD
- Sascha Rau, Device Engineer, Boehringer Ingelheim Pharma GmbH & Co. KG
- Senior Representative, MHRA
- Sheng Qi, Professor of Pharmaceutical Material Science and Technology, Associate Dean for Science Innovation, University of East Anglia
- Steve Hoare, Head of Stds and Regulatory Governance, Secretary, Scientific Director of the BP Commission, Medicines and Healthcare products Regulatory Agency (MHRA)
- Thomas Thueer, Program Lead Autoinjectors, Haselmeier GmbH
- Thomas Wejs Moeller, Director Global Regulatory Affairs - Device, Novo Nordisk
- Tiffany McIntire, Principal Human Factors Engineer, Roche
- Torsten Kneuss, Head of Project Office Medical Devices, Bayer
- Xavier Donnette, Device Program Lead, UCB
- Ying Wang, Head Of Device Development Science, Pfizer
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Leonardo Royal London St Paul's
10 Godliman St, EC4V 5AJ
London, UK
